Generic drug of the therapeutic class: Dermatology
Active ingredients: Flumetasone, Salicylic acid, Coal tar
60 g tube
Local treatment of psoriasis, circumscribed lichenification and dry eczema.
Dosage ALKOTAR 0.02% / 1% / 1.5% Ointment 60 g tube
RESERVED FOR THE ADULT.
1 to 2 applications per day.
This medicine is CONTRAINDICATED in the following situations:
- Hypersensitivity to one of the components,
- oozing dermatoses,
- primitive bacterial, viral, fungal or parasitic infections,
- application on the eyelids.
NOT RECOMMENDED :
- THIS MEDICATION IS GENERALLY NOT RECOMMENDED in case of pregnancy and during breastfeeding:
. Pregnancy: There is no reliable data on teratogenesis in animals. In the clinic, there are currently no data of sufficient relevance to evaluate the possible malformative or fetotoxic effect of coal tars when administered during pregnancy. As a result, the use of this drug is not recommended during pregnancy.
. breastfeeding: in the absence of data, the use of this drug is not recommended during breastfeeding. In no case it will be applied on the breasts.
- Taking salicylates systemically and applying topical salicylic acid should be avoided during the period of use of this drug (see interactions).
Alkotar side effects
- Related to coal tar:
. Folliculitis, primary irritations.
- Corticosteroid related:
Prolonged use of corticosteroids of moderate activity may cause skin atrophy, telangiectasia (to be particularly feared on the face), stretch marks (at the root of the limbs in particular, and occurring more readily in adolescents), secondary ecchymotic purpura to atrophy, skin fragility.
In the face, corticosteroids can create perioral dermatitis or aggravate rosacea.
It can be observed delayed healing of sluggish wounds, pressure ulcers, leg ulcers.
Acneiform or pustular eruptions, hypertrichosis, depigmentations have been reported.
Secondary infections, especially under occlusive dressing or in folds and allergic contact dermatitis have also been reported with the use of local corticosteroids.